Diary

  • Mon
    08
    Apr
    2019

    Royal Marsden Hospital

    Description: In this course I describe the faulty genes, pathways and proteins that drive small cell and non-small cell lung cancer. I also explain the scientific rationale behind targeted treatments in use and in development for these diseases, such as EGFR inhibitors, ALK and ROS1 inhibitors, B-Raf inhibitors, angiogenesis inhibitors and immunotherapy with checkpoint inhibitors.
    Level: Intermediate/Advanced
    Audience: Ideal for pharmacists, research nurses, people from pharmaceutical companies, junior doctors or anyone who has been on one of my other courses. Requires a basic understanding of cancer genetics and cancer cell biology.
    Cost: £150
    To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
    View an outline of the programme

  • Thu
    23
    May
    2019

    Royal Marsden Hospital, London

    Description: In this course I describe the faulty genes, pathways and proteins that drive colorectal, head and neck, pancreatic, oesophageal, gastric and primary liver cancer. I also explain the science behind many targeted treatment approaches for these diseases, including EGFR- and HER2-targeted antibodies, angiogenesis inhibitors and immunotherapy with checkpoint inhibitors.
    Level: Intermediate/Advanced
    Audience: Ideal for pharmacists, research nurses, people from pharmaceutical companies, junior doctors or anyone who has been on one of my other courses. Requires a basic understanding of cancer genetics and cancer cell biology.
    Cost: £150
    To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
    View an outline of the programme

  • Wed
    05
    Jun
    2019

    Half dayRoyal Marsden Hospital, London

    Description: A half-day course repeated morning and afternoon describing the theory behind the new immunotherapy treatments for cancer such as checkpoint inhibitors (ipilimumab, pembrolizumab, nivolumab, atezolizumab, durvalumab), adoptive cell transfer (CAR T cell therapy, infiltrating T cells), and vaccine-based treatments (peptide and DNA vaccines, oncolytic viruses, dendritic cell vaccines).
    Level: Intermediate
    Audience: Ideal for anyone with an A level or equivalent understanding of cell biology and genetics and who works with cancer patients, data or treatments.
    To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
    View an outline of the programme

  • Fri
    21
    Jun
    2019

    Royal Marsden Hospital, London

    Description: In this study day I describe the unique cellular and genetic features of haematological cancers and covers a diverse range of targeted treatments for leukaemias, lymphomas and multiple myeloma. Treatments explained include a wide range of monoclonal antibodies, B cell receptor signalling blockers and JAK2, Bcl-2, FLT3 and CDK inhibitors. I also explore the potential of immunotherapy with checkpoint inhibitors and CAR T cells.
    Level: Intermediate/Advanced
    Audience:Ideal for pharmacists, research nurses, people from pharmaceutical companies, junior doctors or anyone who has been on one of my other courses. Requires a basic understanding of cancer genetics and cancer cell biology.
    Cost: £150
    To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
    View an outline of the programme

  • Tue
    25
    Jun
    2019

    Royal Marsden Hospital

    Description: Using a combination of colourful diagrams and clear explanations, I will describe the gene mutations and other defects that drive ovarian cancer (including fallopian tube and other primary peritoneal cancers). I will also examine how this knowledge impacts treatment choice and explain the science behind chemotherapy and PARP, B-Raf and angiogenesis inhibitors. The day will also include the potential of immunotherapy and novel approaches for treatment, screening and patient monitoring.
    Level: Intermediate
    Audience: Ideal for anyone with an A level or equivalent understanding of cell biology and genetics and who works with cancer patients, data or treatments.
    Cost: £150
    To book, contact: conferenceteam@rmh.nhs.uk or call: 020 7808 2922
    View an outline of the programme

     

  • Fri
    13
    Sep
    2019

    9:45 amCongress Centre, 28 Great Russell Street, London WC1B 3UB

    I will be setting the scene with the science behind CAR-modified T cell therapy as part of a comprehensive day on the history, practicalities and realities of this novel treatment approach. To make enquires about the day contact: meetings@hartleytaylor.co.uk

  • Mon
    28
    Oct
    2019

    This is a FREE 5-week, online course written and co-presented by Elaine on behalf of Cancer Research UK and hosted on the FutureLearn website.

    It will be running again in October/November - exact dates yet to be announced.

    Click here to sign-up on the FutureLearn website.

    Well over 1,000 people have undertaken the course so far. It contains a mixture of videos and articles that explain the science behind cancer treatments such as kinase inhibitors, monoclonal antibodies and immunotherapies. You also hear from cancer nurses, scientists and doctors talking about treatment side effects, the realities of talking to patients, and both the promise and pitfalls of new cancer treatments and biomarkers.

    The course is ideal for anyone new to delivering targeted cancer treatments or immunotherapies to cancer patients.

  • Mon
    04
    Nov
    2019
    Tue
    05
    Nov
    2019

    08.15 - 09.00 Monday & Tuesday morningScottish Events Campus, Glasgow

    For those of you attending this year's NCRI conference in Glasgow, I will be running workshops on Monday and Tuesday morning to explain and unravel the scientific content of each day's programme.

    My workshops are for people who plan to attend the day's lectures whilst fearing that they won’t understand the relevant scientific concepts.

    My workshops will be tailored according to the topics of the plenary sessions at this year's conference.

    Similar to previous years’ workshops, I will use diagrams and illustrations to provide clear, easy-to-understand explanations of complicated biological concepts.

    The workshops are geared towards non-scientists, such as doctors, nurses, trials staff and patients who’d like to get the most out of this year’s conference.

    View the full conference programme

  • Mon
    02
    Dec
    2019

    9;30am - 4pmRoyal Marsden Hospital, London

    Description: This is a one-day course in which I describe the science behind a wide range of licensed and experimental cancer treatments, explaining their mechanism of action at a molecular and cellular level. Treatments described include: growth factor receptor inhibitors, kinase inhibitors, monoclonal antibodies, PARP inhibitors, ALK inhibitors, CDK inhibitors, immunotherapy with checkpoint inhibitors.
    Level: Intermediate/Advanced
    Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine’s other courses
    Cost:
    £150
    To book, contact: conferenceteam@rmh.nhs.uk
    View the day's programme

    Book your place on the Marsden's website

  • Mon
    09
    Dec
    2019

    9:30am - 4pmRoyal Marsden Hospital, London

    Description: A one-day course on the biology and genetics of malignant melanoma and the science behind the latest treatment approaches. Both BRAF/MEK inhibitors and checkpoint inhibitors will be explained and the latest trial data presented. The day will also include an overview of novel treatments such as antigen and DNA vaccines and other agents in early phase trials.
    Level: Intermediate/Advanced
    Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine’s other courses
    Cost:
    £150
    To book, contact: conferenceteam@rmh.nhs.uk
    View the day's programme

    Book your place on the Marsden's website